Neutrophils

Blocking DKK1 Reprograms Neutrophils and Revives Immunotherapy in Bone Metastases

Preclinical data showing that DKK1 inhibition revives checkpoint blockade efficacy against bone tumors have triggered clinical trials of DKN-01 guided by CHI3L3 biomarker research.